Cargando…
Nuclear medicine imaging and therapy of neuroendocrine tumours
Radiolabelled peptides are used for specific targeting of receptors (over-)expressed by tumour cells. Dependent on the kind of labelling and the radionuclide used, these compounds may be utilised for imaging or for therapy. A concise overview is provided on basic principles of designing and developi...
Autores principales: | Gotthardt, Martin, Dijkgraaf, Ingrid, Boerman, Otto C, Oyen, Wim J G |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
e-MED
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1805059/ https://www.ncbi.nlm.nih.gov/pubmed/17114073 http://dx.doi.org/10.1102/1470-7330.2006.9038 |
Ejemplares similares
-
PET imaging of α(v)β(3) integrin expression in tumours with (68)Ga-labelled mono-, di- and tetrameric RGD peptides
por: Dijkgraaf, Ingrid, et al.
Publicado: (2010) -
Molecular imaging of angiogenesis with SPECT
por: Dijkgraaf, Ingrid, et al.
Publicado: (2010) -
(68)Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET
por: Brom, Maarten, et al.
Publicado: (2010) -
Improved labelling of DTPA- and DOTA-conjugated peptides and antibodies with (111)In in HEPES and MES buffer
por: Brom, Maarten, et al.
Publicado: (2012) -
Albumin-derived peptides efficiently reduce renal uptake of radiolabelled peptides
por: Vegt, Erik, et al.
Publicado: (2009)